Tempus AI Innovation & Technology Culture

Tempus is advancing precision medicine through cutting-edge technologies that help physicians and researchers uncover deeper insights from complex biological data. By leveraging advanced sequencing capabilities, teams are helping expand the understanding of disease and enabling more informed treatment and research decisions.

“There aren't a lot of places that do RNA sequencing at our level. RNA sequencing allows for physicians and researchers to get more valuable insights that they can't get from DNA sequencing.”

Tempus approaches innovation with a focus on scalability, building systems that can evolve alongside the company’s expanding products, users and areas of impact. Teams are challenged to create flexible frameworks that support growth today while adapting to the needs of tomorrow.

“Our guiding principle is scalability. The design system must be prescriptive enough to ensure we meet our highest design standards, but flexible enough to be adapted to future requirements. This is no small feat when the business is not only scaling within oncology, but across new areas like neurological disorders, infectious disease and cardiovascular disease, and more in the future. Our user base is expanding in multiple dimensions, so a simple, linear set of guidelines won’t be sufficient.”

Tempus is building technology platforms designed to scale alongside the growing needs of researchers, clinicians and healthcare organizations. Teams work at the intersection of data, cloud infrastructure and advanced analytics, creating secure and scalable systems that enable new discoveries and accelerate innovation in precision medicine.

“Our technology teams are preparing to scale collaboration with external researchers looking to dive into Tempus’ clinical, molecular and imaging data in order to derive new insights and build new models. This not only relies on having secure paths to access large volumes of Tempus’ de-identified, licensed data but also engineering our cloud-based technology platform to support data curation, discovery, analysis and scaled research workflows that have the potential to impact precision medicine materially.”